← Leaderboards
Kenneth Ira Berns
University Of Florida
$3,448,081
Attributed
$3,448,081
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$11,804,276 · 5
By mechanism
M01$8,356,195 · 1
R01$2,886,203 · 2
P50$413,998 · 1
G08$147,880 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Terence R. Flotte$26,412,339
- Arun Srivastava$10,395,461
- Nicholas Muzyczka$10,997,810
- William W Hauswirth$34,023,360
- Barry J. Byrne$9,633,932
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectAdeno Associated Virus GroupTissue /Cell CultureVirus GeneticsVirus IntegrationMethod DevelopmentAdenoviridaeCell TransformationRecombinant VirusTransfection /Expression VectorHela CellsHelper VirusNucleic Acid HybridizationSite Directed MutagenesisVirus ReplicationTranscription FactorUltraviolet RadiationVirus DnaCarcinogensDna ReplicationDna Binding ProteinDna TopoisomerasesGel Electrophoresis
Grant awards (15)
MOLECULAR BIOLOGY OF AAV:ANTI-NEOVASCULARIZATION THERAPY$542,456
R01 · FY2004 · EY
MOLECULAR BIOLOGY OF AAV:ANTI-NEOVASCULARIZATION THERAPY$340,412
R01 · FY2003 · EY
MOLECULAR BIOLOGY OF AAV:ANTI-NEOVASCULARIZATION THERAPY$216,211
R01 · FY2003 · EY
GENERAL CLINICAL RESEARCH CENTER$3,700,466
M01 · FY2002 · RR
MOLECULAR BIOLOGY OF AAV:ANTI-NEOVASCULARIZATION THERAPY$523,608
R01 · FY2002 · EY
GENERAL CLINICAL RESEARCH CENTER$2,685,897
M01 · FY2001 · RR
MOLECULAR BIOLOGY OF AAV:ANTI-NEOVASCULARIZATION THERAPY$510,236
R01 · FY2001 · EY
DEVELOPMENT OF ADENO ASSOCIATED VIRUS/ADENOVIRUS HYBRID$126,320
P50 · FY2001 · HL
GCRC-CAP-JEFFREY W. SKIMMING, M.D.$51,412
M01 · FY2001 · RR
GENERAL CLINICAL RESEARCH CENTER$1,856,725
M01 · FY2000 · RR
MOLECULAR BIOLOGY OF AAV:ANTI-NEOVASCULARIZATION THERAPY$520,866
R01 · FY2000 · EY
DEVELOPMENT OF ADENO ASSOCIATED VIRUS/ADENOVIRUS HYBRID$287,678
P50 · FY2000 · HL
REGULATION OF AAV DNA REPLICATION$232,414
R01 · FY2000 · GM
UNIVERSITY OF FLORIDA IAIMS PLANNING GRANT$147,880
G08 · FY2000 · LM
GCRC-CAP-SANDRA JUUL, M.D., PH.D. (ADDITIONAL TIME)$61,695
M01 · FY2000 · RR